Assessment of women with suspected myocardial ischemia: review of findings of the Women's Ischemia Syndrome Evaluation (WISE) Study.
Coronary artery disease (CAD) is the most common cause of death in women. In general, noninvasive testing in women is less reliable compared with testing in men, and most major clinical trials in CAD have included only a minority of female subjects. The Women's Ischemia Syndrome Evaluation (WISE) Study--sponsored by the National Heart, Lung, and Blood Institute--was initiated to improve diagnostic testing in women. The study consisted of four centers that tested existing methodologies as well as innovative techniques to improve diagnostic testing in women. The WISE study also aimed to clarify physiologic determinants of myocardial ischemia and determine whether angiographically normal coronary arteries are associated with myocardial ischemia. The following discussion provides an overview of the WISE study and reviews the reported and published data from the study.
Lewis
Jannet F
JF
Division of Cardiology, George Washington University Medical Center, Suite 4-414, 2150 Pennsylvania Avenue NW, Washington, DC 20037, USA.
McGorray
Susan P
SP
Pepine
Carl J
CJ
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002985:Clinical Protocols; D017023:Coronary Angiography; D003935:Diagnostic Techniques, Cardiovascular / Q000592:standards*; D025401:Echocardiography, Stress; D005080:Exercise Test; D005260:Female; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000175:diagnosis*; D010761:Phosphorus Radioisotopes; D012680:Sensitivity and Specificity; D016387:Women's Health
D000924:Anticholesteremic Agents; D010761:Phosphorus Radioisotopes